Keishi Miyata Selected Research

Angiopoietin-Like Protein 2

1/2021	Stroma-derived ANGPTL2 establishes an anti-tumor microenvironment during intestinal tumorigenesis.
12/2019	Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity.
1/2018	Circulating ANGPTL2 Levels Increase in Humans and Mice Exhibiting Cardiac Dysfunction.
1/2017	ANGPTL2 expression in the intestinal stem cell niche controls epithelial regeneration and homeostasis.
2/2016	Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-β signaling in chronic kidney disease.
1/2016	Macrophage-Derived Angiopoietin-Like Protein 2 Exacerbates Brain Damage by Accelerating Acute Inflammation after Ischemia-Reperfusion.
1/2016	Mice Deficient in Angiopoietin-like Protein 2 (Angptl2) Gene Show Increased Susceptibility to Bacterial Infection Due to Attenuated Macrophage Activity.
3/2015	ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.
9/2014	Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis.
5/2014	Diverse roles of ANGPTL2 in physiology and pathophysiology.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keishi Miyata Research Topics

Disease

18	Inflammation (Inflammations) 01/2018 - 09/2009
17	Obesity 11/2021 - 04/2005
9	Neoplasms (Cancer) 01/2022 - 10/2003
6	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2011
5	Atherosclerosis 11/2021 - 01/2009
4	Atherosclerotic Plaque (Atheroma) 11/2020 - 01/2009
4	Metabolic Diseases (Metabolic Disease) 01/2018 - 05/2010
4	Insulin Resistance 04/2013 - 04/2005
3	Carcinogenesis 01/2022 - 12/2011
3	Heart Failure 01/2021 - 01/2018
3	Hyperplasia 04/2013 - 04/2005
2	Fatty Liver 11/2021 - 04/2014
2	Rupture 11/2020 - 10/2010
2	Hypoxia (Hypoxemia) 11/2020 - 01/2018
2	Muscular Atrophy (Muscle Atrophy) 01/2019 - 01/2018
2	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 01/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 03/2015
2	Fibrosis (Cirrhosis) 10/2016 - 02/2016
2	Ischemia 01/2016 - 05/2008
2	Rheumatoid Arthritis 01/2016 - 05/2010
2	Breast Neoplasms (Breast Cancer) 03/2015 - 09/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2014 - 12/2011
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Intestinal Neoplasms (Intestinal Cancer) 01/2022
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Cardiogenic Shock 12/2021
1	Hyperglycemia 12/2021
1	Myocardial Infarction 12/2021
1	Dyslipidemias (Dyslipidemia) 11/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 11/2021
1	Premature Aging 01/2020
1	Weight Gain 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2019
1	Kidney Neoplasms (Kidney Cancer) 06/2019
1	Hypertrophy 01/2019
1	Autism Spectrum Disorder 01/2018
1	Sarcopenia 01/2018
1	Autistic Disorder (Autism) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Cachexia 01/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2016
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2016
1	Chronic Renal Insufficiency 02/2016

Drug/Important Bio-Agent (IBA)

21	Angiopoietin-Like Protein 2IBA 01/2021 - 09/2009
12	Proteins (Proteins, Gene)FDA Link 06/2019 - 10/2003
6	Messenger RNA (mRNA)IBA 01/2020 - 01/2009
5	CytokinesIBA 01/2016 - 05/2010
4	Apolipoproteins E (ApoE)IBA 11/2021 - 02/2009
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 04/2005
3	Angiopoietin-like ProteinsIBA 01/2018 - 04/2012
3	Insulin (Novolin)FDA Link 01/2018 - 01/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 04/2013
3	Transcription Factor CHOPIBA 09/2015 - 10/2010
3	AngiopoietinsIBA 05/2008 - 10/2003
2	Blood Glucose (Blood Sugar)IBA 12/2021 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 11/2021 - 04/2014
2	CholesterolIBA 11/2021 - 10/2010
2	ApolipoproteinsIBA 11/2020 - 04/2014
2	Matrix Metalloproteinases (MMPs)IBA 11/2020 - 01/2014
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2016 - 09/2015
2	EnzymesIBA 01/2016 - 01/2014
2	LipidsIBA 01/2009 - 04/2005
2	HydrolasesIBA 01/2008 - 04/2005
1	osteoblast cadherinIBA 01/2022
1	CateninsIBA 01/2022
1	EpitopesIBA 11/2021
1	VaccinesIBA 11/2021
1	Protein Subunit VaccinesIBA 11/2021
1	Angiopoietin-Like Protein 3IBA 11/2021
1	Peptides (Polypeptides)IBA 11/2021
1	oxidized low density lipoproteinIBA 11/2021
1	LDL CholesterolIBA 11/2021
1	CarcinogensIBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Febuxostat FDA Link 11/2020
1	Xanthine OxidaseIBA 11/2020
1	gnemonoside AIBA 01/2020
1	gnetin CIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 06/2019
1	MicroRNAs (MicroRNA)IBA 06/2019
1	HMGB2 ProteinIBA 01/2019
1	Taurine FDA Link 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	neuregulin-4IBA 01/2018
1	EGF Family of ProteinsIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	ChromatinIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	Transfer RNA (tRNA)IBA 01/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2017

Therapy/Procedure

6	Therapeutics 12/2021 - 05/2010
2	Denervation 01/2019 - 01/2018
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2014 - 10/2010
1	Extracorporeal Membrane Oxygenation 12/2021
1	Renal Dialysis (Hemodialysis) 01/2020
1	Resistance Training 01/2018